Never tear us a-PARP: Dealing with DNA lesions during mitosis

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)
232 Downloads (Pure)


Tumors defective in homologous recombination (HR) are highly sensitive to poly ADP-ribose polymerase (PARP) inhibition, however the cell biological mechanisms underlying this synthetic lethality remain elusive. We recently identified that PARP inhibitor-induced DNA lesions persist until mitosis, subsequently causing mitotic chromatin bridges, multinucleation and apoptosis. Here, we discuss the implications of these findings.

Original languageEnglish
Article numbere1382670
Number of pages4
JournalMolecular & Cellular Oncology
Issue number1
Publication statusPublished - 2018


  • Journal Article
  • checkpoint
  • olaparib
  • Mitosis
  • PARP
  • BRCA1/2

Cite this